glp 1 and cancer JCI Do GLP-1 drugs cause cancer?

These medications are driving the market, supported by strong intellectual property laws, extensive clinical research networks, and comprehensive payer reimbursement systems that facilitate rapid market uptake

They all shared the same wide dose range of 10 g/kg to 10 ng/kg, and high therapy range [11]

In a post-hoc analysis of LEADER, the use of liraglutide in those with CKD was safe, with no difference in the frequency of serious adverse events between those participants with and without CKD [96]

[2] [3] Diverticular disease is common in industrialized nations, affecting up to 60% of the population over age 60

Further fine-tuning of the treatment regime can then be guided by metabolite profiling